posted on 2014-04-21, 09:39authored byDavid T. Fox, Emily N. Schmidt, Hongzhao Tian, Suraj Dhungana, Michael C. Valentine, Nicole V. Warrington, Paul D. Phillips, Kellan B. Finney, Emily K. Cope, Jeff G. Leid, Charles A. Testa, Andrew T. Koppisch
IPP and DMAPP are formed through the mevalonate pathway (left) in mammals, fungi and plants and through the methylerythritol phosphate (MEP) pathway (right) in many bacteria, green algae, and plant chloroplasts. Fosmidomycin inhibits formation of IPP and DMAPP (and thus late stage isoprenoid compounds) through disruption of the MEP pathway.